Details of the Drug Formulations

General Information of Drug (ID: DMJFZDL)

Drug Name
Naphazoline Drug Info
Synonyms
Antan; Clearine; Nafazolin; Nafazolina; Nafazoline; Naphazolinum; Naphthizine; Opcon; Nafazolina [DCIT]; Nafazoline [Spanish]; Naphazoline Monohydrochloride; Naphazolinum [Latin]; Enamine_000333; Alpha-Naphthylmethyl imidazoline; Ciba 2020/R; Nafazolin (TN); Naphazoline (INN); Naphazoline [INN:BAN]; Naphazolinum [INN-Latin]; AK-968/41090774; 2-(1-Naphthylmethyl)-2-imidazoline; 2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole; 2-(Naphthyl-(1')-methyl)imidazolin; 2-(Naphthyl-(1')-methyl)imidazolin [German]; 2-(alpha-Naphthylmethyl)-imidazoline; 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole; 4,5-Dihydro-2-(1-naphthylmethyl)imidazole
Indication
Disease Entry ICD 11 Status REF
Hyperaemia 9A61-9B7Y Approved [1]
Itching 1F28-1G07 Approved [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
4436
ChEBI ID
CHEBI:93363
CAS Number
835-31-4
TTD ID
D0O6IZ
ACDINA ID
D01273

Full List of Drug Formulations Containing This Drug

Naphazoline 0.05% solution
Company Formulation ID FDA Description
Duy Drugs F23837 Sodium Chloride; Benzalkonium Chloride; Sodium Bisulfite; Water; Sodium Citrate
------------------------------------------------------------------------------------
Naphazoline 0.012% solution
Company Formulation ID FDA Description
Sato Pharmaceutical Co. Ltd. F23836 Camphor(Synthetic); Benzalkonium Chloride; Sodium Chloride; Boric Acid; Sodium Borate; Water
------------------------------------------------------------------------------------
Naphazoline 0.01% solution
Company Formulation ID FDA Description
International Nature Nutraceuticals F23835 Boric Acid; Sodium Borate; Edetate Disodium; Thimerosal; Water
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015